Point72 Asia (Singapore)’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$230K Buy
+23,858
New +$211K 0.04% 273
2025
Q2
Sell
-65,876
Closed -$471K 1203
2025
Q1
$471K Buy
65,876
+8,035
+14% +$59.8K 0.12% 140
2024
Q4
$447K Buy
+57,841
New +$543K 0.12% 145
2024
Q2
Sell
-928
Closed -$19.6K 1426
2024
Q1
$19.6K Buy
+928
New +$16.5K 0.01% 963

Other funds holding RGNX

Point72 Asia (Singapore)'s RGNX Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Regenxbio (RGNX) in Q3 2025: 23,858 shares worth $230K. The stake represents 0.04% of the portfolio and ranks #273 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in RGNX as recently as Q1 2025.

Point72 Asia (Singapore) first reported a position in RGNX in Q1 2024 and has held it in 4 quarters since. The position peaked at $471K in Q1 2025. 166 funds tracked by Wall St. Rank hold RGNX as of Q3 2025.

  • Point72 Asia (Singapore) held 23,858 shares of Regenxbio worth $230K as of Q3 2025.
  • Regenxbio was a new Point72 Asia (Singapore) position in Q3 2025.
  • Regenxbio made up 0.04% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #273 holding.
  • Point72 Asia (Singapore) first reported a position in Regenxbio in Q1 2024 and has held it in 4 quarters since.
  • Point72 Asia (Singapore)'s Regenxbio position peaked at $471K in Q1 2025.
  • 166 funds tracked by Wall St. Rank held Regenxbio as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.